Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Concert Pharmaceuticals Inc
Concert Pharmaceuticals Inc_20100107
  

Concert Pharmaceuticals Inc patents

Recent patent applications related to Concert Pharmaceuticals Inc. Concert Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Concert Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Concert Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Concert Pharmaceuticals Inc-related inventors




Date Concert Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
10/05/17Morphinan compounds
09/14/17Substituted triazolobenzodiazepines
08/24/17Deuterated derivatives of ruxolitinib
08/03/17Methods of treating hyperglycemia
07/06/17Deuterated baricitinib
05/25/17Deuterated momelotinib
05/18/17Deuterated cftr potentiators
02/09/17Morphinan compounds
02/02/17Substituted xanthine derivatives
01/19/17Deuterated ibrutinib
12/01/16Substituted triazolobenzodiazepines
11/10/164-hydroxybutyric acid analogs
10/06/16Morphinan compounds
09/15/16Substituted isoindoline-1,3-dione derivatives
07/28/16Substituted thienotriazolodiazapines
06/09/16Deuterated rigosertib
05/26/16Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurolgical diseases, intractable and chronic pain and brain injury
04/28/16Inhibitors of cholesterol ester transfer protein
03/24/16Pyrazinoisoquinoline compounds
03/10/16Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
03/03/16Pyrazinoisoquinoline compounds
02/11/16Deuterated cftr potentiators
02/04/16Deuterated 2-amino-3-hydroxypropanoic acid derivatives
01/28/16Deuterated palbociclib
01/14/16Deuterated pacritinib
12/31/15Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
12/24/15Derivatives of pyrazole-substituted amino-heteroaryl compounds
12/17/15Deuterated momelotinib
12/03/154-hydroxybutyric acid analogs
11/26/15Morphinan compounds
11/26/15Substituted dioxopiperidinyl phthalimide derivatives
11/19/15Methods of treating chronic kidney disease characterized by macroalbuminuria
11/12/15Substituted xanthine derivatives
10/22/15Solid forms of
10/22/15Deuterated alk inhibitors
10/22/15Fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds
10/15/15Carbamoylpyridone derivatives
10/15/15Deuterated ponatinib
10/01/15Substituted xanthine derivatives
08/27/15Deuterated derivatives of ruxolitinib
08/06/15Deuterated baricitinib
07/30/15Deuterated 4-hydroxybutyric acid analogs
07/30/15Deuterated ibrutinib
07/16/15Deuterated derivatives of ruxolitinib
06/25/15Deuterated vercirnon
06/18/15Deuterated carfilzomib
06/18/15Deuterated idebenone
06/11/15Polymorphs of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
05/21/15Pyrazinoisoquinoline compounds
04/30/15Form 2 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
04/30/15Substituted xanthine derivatives
04/23/15Substituted triazolo-pyridazine derivatives
04/16/15Substituted isoindoline-1,3-dione derivatives
04/09/15Form 5 polymorph of 7-(tert-butyl-d9)-3-(2,5-difluorophenyl)-6-((1-methyl-1h-1,2,4-triazol-5-yl)methoxy)-[1,2,4]triazolo[4,3-b]pyridazine
04/09/15Synthesis of deuterated morpholine derivatives
04/09/15Deuterated cftr potentiators
04/02/15Deuterated rigosertib
03/12/15Morphinan compounds
01/08/15Inhibitors of cholesterol ester transfer protein
11/20/144-hydroxybutyric acid analogs
11/13/14Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
10/23/14Morphinan compounds
10/02/14Substituted xanthine derivatives
07/31/14Carbamoylpyridone derivatives
06/05/14Tetrahydronaphthalene derivatives
Patent Packs
05/08/14Deuterated n-butyl bumetanide
05/01/14Substituted xanthine derivatives
04/24/14Morphinan compounds
02/13/14Method of utilizing recycled deuterium oxide in the synthesis of deuterated compounds
01/23/14Substituted triazolophthalazine derivatives
01/16/14Pyrimidine derivatives
01/16/14Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
01/16/14Deuterated benzo[d][1,3]-dioxol derivatives
01/02/14Derivatives of pyrazole-substituted amino-heteroaryl compounds
12/26/13Substituted isoindoline-1,3-dione derivatives
12/05/13Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)-dione
11/28/13Substituted triazolo-pyridazine derivatives
11/21/13Morphinan compounds
10/24/13Process for preparing an enantiomerically enriched, deuterated secondary alcohol from a corresponding ketone without reducing deuterium incorporation
08/29/13Substituted triazolo-pyridazine derivatives
Patent Packs
06/13/13Substituted dioxopiperidinyl phthalimide derivatives
05/23/13Analogues of cilostazol
05/16/13N-phenyl-2-pyrimidineamine derivatives
05/02/13Novel pyrimidinecarboxamide derivatives
04/18/13Heterocyclic kinase inhibitors
01/31/13Pyrazinoisoquinoline compounds
01/17/13Deuterated pirfenidone
01/10/134-hydroxybutyric acid analogs
11/22/12Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
10/25/12Prostacyclin derivatives
10/18/12Analogues of cilostazol
10/04/12Substituted isoindoline-1,3-dione derivatives
09/20/12Fluorinated diaryl urea derivatives
08/09/12Substituted xanthine derivatives
06/14/12Pyrazinoisoquinoline compounds
06/07/12Deuterated fingolimod
05/17/12Tetrahydronaphthalene derivatives
05/17/124-hydroxybutyric acid analogs
01/05/12Substituted triazolo-pyridazine derivatives
12/22/11Deuterated pyridinones
12/15/11Morphinan compounds
12/08/11Pyridineamine derivatives
12/08/114-aminoquinazoline prodrugs
11/24/11Substituted dioxopiperidinyl phthalimide derivatives
11/17/11Substituted oxazolidinone derivatives
10/20/11Derivatives of dimethylcurcumin
10/13/11Deuterated 2-amino-3-hydroxypropanoic acid derivatives
09/29/11Tetrahydronaphthalene derivatives
09/22/11Morphinan compounds
08/11/11Deuterated macrocyclic inhibitors of viral ns3 protease
Social Network Patent Pack
08/11/11Methionine analogs and methods of using same
07/14/11Substituted triazolophthalazine derivatives
07/14/11Substituted benzimidazoles
06/30/11Deuterium enriched analogues of tadalafil as pde5 inhibitors
06/30/11Triazolyl tropane derivatives
06/23/11Deuterium labelled derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof
06/16/11Niacin prodrugs and deuterated versions thereof
05/19/11Vandetanib derivatives
04/28/114-aminoquinazoline derivatives and methods of use thereof
04/21/11Pharmaceutical calcimimetics
Patent Packs
04/07/11Substituted imidazotriazines
03/31/11Substituted xanthine derivatives
03/17/11Substituted triazolo-pyridazine derivatives
03/10/11Derivatives of gefitinib
03/10/11Substituted xanthine derivatives
03/10/11Substituted cycloalcano[e and d] pyrazolo [1,5-a]pyrimidines/antagonists of serotonin 5-ht6 receptors and methods for production and the use thereof
03/03/11Substituted xanthine derivatives
12/23/10Substituted isoindoline-1,3-dione derivatives
12/02/10Hydroxyethylamino sulfonamide derivatives
10/14/10Quinazoline derivatives and methods of treatment
10/07/10Prostacyclin derivatives
09/30/10Analogues of cilostazol
09/02/10N-phenyl-2-pyrimidineamine derivatives
09/02/10Deuterated benzo[d][1,3]-dioxol derivatives
07/22/10Prostacyclin derivatives
06/24/10Synthesis of deuterated morpholine derivatives
06/17/10Novel pyrimidinecarboxamide derivatives
06/03/10Novel tetrahydro-1h-pyrido[4,3-b]indoles
05/13/10Piperazine derivatives
03/25/10Alpha 1a-adrenoceptor antagonists
03/04/10Substituted triazolo-pyridazine derivatives
02/04/10Novel 1,2,3,4- tetrahydroquinoline derivatives
01/07/10Naphthyl(ethyl) acetamides
12/31/09Prostacyclin derivatives
11/26/09Dibenzothiazepine derivatives
10/29/093-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
10/29/09Quinazoline derivatives and methods of treatment
10/29/09Catalytic antibodies and a producing same
10/29/09Piperazine derivatives
10/15/09Biphenyl-pyrazolecarboxamide compounds
Patent Packs
09/24/09Substituted xanthine derivatives
08/06/093-(dihydro-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
07/23/09Derivatives of gefitinib
07/09/09Deuterated fingolimod
06/11/09Heterocyclic kinase inhibitors
06/11/09Alpha-aminoamide derivatives
06/04/09Deuterated lorcaserin
06/04/09Synthesis of deuterated catechols and benzo[d][1,3]dioxoles and derivatives thereof
05/28/09Pyrimidinedione derivatives
05/21/09Deuterated pirfenidone
04/23/09Deuterated etravirine
02/05/09Novel pyrimidinecarboxamide derivatives
02/05/09Azapeptide derivatives
01/07/10Naphthyl(ethyl) acetamides







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Concert Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Concert Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';